EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-8.45 Cr | ₹16 Cr | ₹-3.10 Cr | ₹-2.64 Cr | ₹2.07 Cr |
What is the latest Cash Flow from Financing Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-8.45 Cr |
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹-3.10 Cr |
| Mar2023 | ₹-2.64 Cr |
| Mar2022 | ₹2.07 Cr |
How is Cash Flow from Financing Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-8.45 Cr | Negative | |
| Mar2025 | ₹16 Cr | Positive | |
| Mar2024 | ₹-3.10 Cr | Negative | |
| Mar2023 | ₹-2.64 Cr | Negative | |
| Mar2022 | ₹2.07 Cr | - | |
Compare Cash Flow from Financing Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹251.3 Cr | 6.7% | 3.8% | -39% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,497.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,146.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,474.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,349.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,989.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 6.7% |
3.8% |
-39% |
| SENSEX | 7% |
11.5% |
-3.5% |
You may also like the below Video Courses